|
|
Volumn 5, Issue 6, 2004, Pages 741-744
|
|
Iconix Pharmaceuticals, Inc. - Removing barriers to efficient drug discovery through chemogenomics
a
|
|
Author keywords
Bioinformatics; Biomarkers; Chemogenomics; Drug profiling; Drug Signatures ; DrugMatrix ; Expression arrays; Genomics; Integrated database; Toxicogenomics
|
|
Indexed keywords
BIOLOGICAL MARKER;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
NONSTEROID ANTIINFLAMMATORY AGENT;
ACCESS TO INFORMATION;
ARTICLE;
BIOINFORMATICS;
BIOTECHNOLOGY;
CHEMICAL GENETICS;
COMMERCIAL PHENOMENA;
COST BENEFIT ANALYSIS;
DATA BASE;
DRUG DESIGN;
DRUG INDUSTRY;
DRUG MARKETING;
DRUG MONITORING;
DRUG RESEARCH;
FOOD AND DRUG ADMINISTRATION;
GENE EXPRESSION PROFILING;
HUMAN;
INFORMATION PROCESSING;
LIVER TOXICITY;
NONHUMAN;
PROCESS OPTIMIZATION;
CLINICAL TRIALS;
DRUG DESIGN;
DRUG INDUSTRY;
GENETIC RESEARCH;
GENOMICS;
HUMANS;
TECHNOLOGY, PHARMACEUTICAL;
|
|
EID: 4544285933
PISSN: 14622416
EISSN: None
Source Type: Journal
DOI: 10.1517/14622416.5.6.741 Document Type: Article |
|
Times cited : (15)
|
|
References (0)
|
